Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis
Fatemeh Safari, Safar Farajnia, Maryam Arya, et al.
Immunopharmacology and Immunotoxicology (2018) Vol. 40, Iss. 3, pp. 201-211
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

New Frontiers in the Treatment of Type 1 Diabetes
Jeremy Warshauer, Jeffrey A. Bluestone, Mark S. Anderson
Cell Metabolism (2019) Vol. 31, Iss. 1, pp. 46-61
Open Access | Times Cited: 197
Function and Role of Regulatory T Cells in Rheumatoid Arthritis
Qi Jiang, Guocan Yang, Qi Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 171
CRISPR Cpf1 proteins: structure, function and implications for genome editing
Fatemeh Safari, Khadijeh Zare, Manica Negahdaripour, et al.
Cell & Bioscience (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 169
Overview of CD24 as a new molecular marker in ovarian cancer
Vahideh Tarhriz, Mojgan Bandehpour, Siavoush Dastmalchi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 3, pp. 2134-2142
Closed Access | Times Cited: 110
The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection
Yuxuan He, Wei Yan, Likun Long, et al.
Genes (2023) Vol. 14, Iss. 4, pp. 850-850
Open Access | Times Cited: 21
Application and perspective of CRISPR/Cas9 genome editing technology in human diseases modeling and gene therapy
Manling Zhang, Hongbin Li, Yong Jin
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 13
Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis
Jiaqian Zhang, Hongjiang Liu, Yuehong Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Development and application of CRISPR/Cas9 technologies in genomic editing
Cui Zhang, Renfu Quan, Jinfu Wang
Human Molecular Genetics (2018) Vol. 27, Iss. R2, pp. R79-R88
Open Access | Times Cited: 67
CRISPR systems: Novel approaches for detection and combating COVID-19
Fatemeh Safari, Mohammad Afarid, Banafsheh Rastegari, et al.
Virus Research (2021) Vol. 294, pp. 198282-198282
Open Access | Times Cited: 54
Emerging technology has a brilliant future: the CRISPR-Cas system for senescence, inflammation, and cartilage repair in osteoarthritis
Shicheng Jia, Rongji Liang, Jiayou Chen, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
The Role of Long Non-Coding RNA in Rheumatoid Arthritis
Kajetan Kiełbowski, Maciej Ćmil, Wojciech Jerzy Biniek, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 560-560
Open Access
Defective T-Cell Apoptosis and T-Regulatory Cell Dysfunction in Rheumatoid Arthritis
Charles J. Malemud
Cells (2018) Vol. 7, Iss. 12, pp. 223-223
Open Access | Times Cited: 58
The interaction of phages and bacteria: the co-evolutionary arms race
Fatemeh Safari, Mehrdad Sharifi, Safar Farajnia, et al.
Critical Reviews in Biotechnology (2019) Vol. 40, Iss. 2, pp. 119-137
Closed Access | Times Cited: 51
Immunoengineering the next generation of arthritis therapies
Molly Klimak, Robert J. Nims, Lara Pferdehirt, et al.
Acta Biomaterialia (2021) Vol. 133, pp. 74-86
Open Access | Times Cited: 34
Cell-based therapies for rheumatoid arthritis: opportunities and challenges
Yujing Li, Zhu Chen
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 23
Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives
Dong‐Ho Nahm
Life (2023) Vol. 13, Iss. 8, pp. 1674-1674
Open Access | Times Cited: 12
Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
Pan Lin Xin, Li Fan Jie, Qian Cheng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Sanjay Rathod
Diabetology (2022) Vol. 3, Iss. 1, pp. 79-96
Open Access | Times Cited: 21
Dihydroartemisinin derivative DC32 attenuates collagen-induced arthritis in mice by restoring the Treg/Th17 balance and inhibiting synovitis through down-regulation of IL-6
Menglin Fan, Yanan Li, Chun-hua Yao, et al.
International Immunopharmacology (2018) Vol. 65, pp. 233-243
Closed Access | Times Cited: 37
Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation
Braulio A. Marfil‐Garza, Joshua Hefler, Mario Bermúdez de León, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 198-218
Open Access | Times Cited: 28
Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
Franziska Roth‐Walter, Ian M. Adcock, Cristina Benito‐Villalvilla, et al.
Allergy (2020) Vol. 76, Iss. 1, pp. 90-113
Open Access | Times Cited: 27
Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín, et al.
Elsevier eBooks (2019), pp. 191-424
Closed Access | Times Cited: 28
Knockout of caspase-7 gene improves the expression of recombinant protein in CHO cell line through the cell cycle arrest in G2/M phase
Fatemeh Safari, Bahman Akbari
Biological Research (2022) Vol. 55, Iss. 1
Open Access | Times Cited: 12
Anticancer Impacts of Terminalia catappa Extract on SW480 Colorectal Neoplasm Cell Line
Dariush Shanehbandi, Habib Zarredar, Milad Asadi, et al.
Journal of Gastrointestinal Cancer (2019) Vol. 52, Iss. 1, pp. 99-105
Closed Access | Times Cited: 21
Immune system and new avenues in Parkinson’s disease research and treatment
Ava Nasrolahi, Fatemeh Safari, Mehdi Farhoudi, et al.
Reviews in the Neurosciences (2019) Vol. 30, Iss. 7, pp. 709-727
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top